medline.ch Respirationstrakt Zystische Fibrose

	Working towards consensus in the management of pediatric chronic rhinosinusitis in cystic fibrosis. Int J Pediatr Otorhinolaryngol Jayawardena ADL, Fracchia MS, Bartley BL, Yonker LM, Lapey A, Virgin F, Hartnick CJ. PMID: 32446041 [PubMed - as supplied by publisher]
	An observational study of the lung clearance index throughout childhood in cystic fibrosis: Early years matter. Eur Respir J Davies G, Stanojevic S, Raywood E, Duncan JA, Stocks J, Lum S, Bush A, Viviani L, Wade A, Calder A, Owens CM, Goubau C, Carr SB, Bossley CJ, Pao C, Aurora P, London Cystic Fibrosis Collaboration.. PMID: 32444409 [PubMed - as supplied by publisher]
	Ceftolozane/Tazobactam for Treating Children With Exacerbations of Cystic Fibrosis Due to Pseudomonas aeruginosa: A Review of Available Data. Front Pediatr Garazzino S, Altieri E, Silvestro E, Pruccoli G, Scolfaro C, Bignamini E. PMID: 32432060 [PubMed]
	How do cystic fibrosis patients experience parenthood? A systematic review. J Health Psychol Jacob A, Journiac J, Fischer L, Astrologo L, Flahault C. PMID: 32431218 [PubMed - as supplied by publisher]
	Multivariate joint modeling to identify markers of growth and lung function decline that predict cystic fibrosis pulmonary exacerbation onset. BMC Pulm Med Andrinopoulou ER, Clancy JP, Szczesniak RD. PMID: 32429862 [PubMed - in process]
	Laboratory biomarkers for lung disease severity and progression in cystic fibrosis. Clin Chim Acta Bene Z, Fejes Z, Macek M Jr, Amaral MD, Balogh I, Nagy B Jr. PMID: 32428503 [PubMed - as supplied by publisher]
	Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease. Genes (Basel) Strub MD, McCray PB Jr. PMID: 32414011 [PubMed - in process]
	Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis. Cochrane Database Syst Rev Smith S, Ratjen F, Remmington T, Waters V. PMID: 32412092 [PubMed - in process]
	Longitudinal Associations of the Cystic Fibrosis Airway Microbiome and Volatile Metabolites: A Case Study. Front Cell Infect Microbiol Hahn A, Whiteson K, Davis TJ, Phan J, Sami I, Koumbourlis AC, Freishtat RJ, Crandall KA, Bean HD. PMID: 32411616 [PubMed - in process]
	Tablet and web-based audiometry to screen for hearing loss in adults with cystic fibrosis. Thorax Vijayasingam A, Frost E, Wilkins J, Gillen L, Premachandra P, Mclaren K, Gilmartin D, Picinali L, Vidal-Diez A, Borsci S, Ni MZ, Tang WY, Morris-Rosendahl D, Harcourt J, Elston C, Simmonds NJ, Shah A. PMID: 32409613 [PubMed - as supplied by publisher]
	Breaking the diagnosis of cystic fibrosis to parents: A process not a one-off event. Paediatr Respir Rev Bryon M. PMID: 32409170 [PubMed - as supplied by publisher]
	Bronchial Infection due to Pseudomonas Aeruginosa in Patients with Cystic Fibrosis Diagnosed in Neonatal Screening. Arch Bronconeumol Ayats Vidal R, Bosque García M, García González M, Asensio de la Cruz Ó. PMID: 32404239 [PubMed - as supplied by publisher]
	The Microbiome in Cystic Fibrosis Pulmonary Disease. Genes (Basel) Françoise A, Héry-Arnaud G. PMID: 32403302 [PubMed - in process]
	Synthesis and Therapeutic Applications of Iminosugars in Cystic Fibrosis. Int J Mol Sci Esposito A, D'Alonzo D, Fenza M, Gregorio E, Tamanini A, Lippi G, Dechecchi MC, Guaragna A. PMID: 32397443 [PubMed - in process]
	Immunomodulation in Cystic Fibrosis: Why and How? Int J Mol Sci Giacalone VD, Dobosh BS, Gaggar A, Tirouvanziam R, Margaroli C. PMID: 32397175 [PubMed - in process]
	The role of essential fatty acids in cystic fibrosis and normalizing effect of fenretinide. Cell Mol Life Sci Gari, Dumut DC, Shah J, De Sanctis JB, Radzioch D. PMID: 32394023 [PubMed - as supplied by publisher]
	Prevalence of constipation in cystic fibrosis patients: a systematic review of observational studies. J Pediatr (Rio J) Stefano MA, Poderoso RE, Mainz JG, Ribeiro JD, Ribeiro AF, Lomazi EA. PMID: 32389617 [PubMed - as supplied by publisher]
	Anti-inflammatory effects of lenabasum, a cannabinoid receptor type 2 agonist, on macrophages from cystic fibrosis. J Cyst Fibros Tarique AA, Evron T, Zhang G, Tepper MA, Morshed MM, Andersen ISG, Begum N, Sly PD, Fantino E. PMID: 32387042 [PubMed - as supplied by publisher]
	Restoration of exocrine pancreatic function in older children with cystic fibrosis on ivacaftor. Paediatr Respir Rev Nichols AL, Davies JC, Jones D, Carr SB. PMID: 32386958 [PubMed - as supplied by publisher]
	Improved residual fat malabsorption and growth in children with cystic fibrosis treated with a novel oral structured lipid supplement: A randomized controlled trial. PLoS One Stallings VA, Tindall AM, Mascarenhas MR, Maqbool A, Schall JI. PMID: 32384122 [PubMed - in process]

Artikel 1 - 20 / 15106

Seite 1 von 756



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung